GlassScriptPhysician profile
Kimberly Bloomberg
NPI 1962897967
$2,115.15
in general payments reported to CMS, 2019-2025
17 companies · $512 in 2025
The $512 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $93.51 · 2021: $149 · 2022: $174 · 2023: $533 · 2024: $480 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,524.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $625.40 | 2019-2024 | Jornay Pm |
| Corium, LLC | $394.96 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $199.32 | 2025 | Jornay Pm |
| Sanofi-Aventis U.S. LLC | $151.52 | 2024-2025 | |
| Tris Pharma INC | $145.68 | 2021-2025 | Dyanavel Xr, Onyda Xr |
| Cranial Technologies, INC | $98.66 | 2020-2025 | Doc Band |
| Electromed, INC. | $96.33 | 2021-2022 | |
| Kaleo, INC. | $76.14 | 2019-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $75.34 | 2019-2023 | Vaxelis, Vaxneuvance, Rotateq |
| Supernus Pharmaceuticals, INC. | $71.07 | 2023-2024 | Qelbree, Qelbree |
| Pfizer INC. | $40.71 | 2022-2023 | |
| Shire North American Group INC | $39.71 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $33.82 | 2025 | Neffy |
| Vertical Pharmaceuticals, LLC | $20.34 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.80 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $14.82 | 2020 | |
| Alk-Abello, INC | $14.53 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Bloomberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.